Menlo Park, CA (PRWEB) October 15, 2014
The OutsourcePharma Advisory Board is proud to announce that the number of pharmaceutical sponsor reviews of Contract Research Organizations (CROs) submitted by its members has surpassed its growth milestone with total reviews more than doubling since September. The CRO reviews database features detailed YELP-like sponsor-based reviews of CROs including 14 performance-based metrics across key criteria used by outsourcing professionals to evaluate current and potential partners, feedback about study experiences and willingness to recommend the CRO.
“With the introduction of the CRO Reviews Database, the OutsourcePharma Advisory Board has brought a unique resource to the pharmaceutical outsourcing community. With its first growth milestone surpassed, and several of the leading Top-10 global CROs subscribed, the value of this resource has been validated. I am pleased to see the rich content and insight contained within the reviews for leading CROs including Quintiles, Covance, Parexel, Icon, Charles River and many others.” said Jon Meyer, Co-founder of the OutsourcePharma Advisory Board.
There are significant opportunities for outsourcing professionals, CROs and industry analysts to benefit from a subscription to the OutsourcePharma Advisory Board including access to sponsor-provided CRO performance metrics and detailed reviews, submission of industry resources via blogs and white papers, advisory board site sponsorship and consulting and market research engagements with Life Science Strategy Group (LSSG).
“I couldn’t be happier with the quality and content of the CRO reviews. There are some real nuggets of wisdom for our subscribers.” added Meyer.
To learn more about the OutsourcePharma Advisory Board, please visit
About Life Science Strategy Group, LLC
Life Science Strategy Group, LLC specializes in strategic consulting, market research engagements and syndicated publications across a variety of therapeutic, technology and service industries including contract research services, pharmaceutical, biotechnology, medical devices, diagnostics and drug discovery. It provides oversight and administers The OutsourcePharma Advisory Board.